Die Rallybio Corporation führt einen Reverse Stock Split im Verhältnis 1:8 durch. Die Maßnahme tritt am 6. Februar 2026 in Kraft und soll den Aktienkurs anheben, um die Anforderungen für die Notierung am Nasdaq Capital Market zu erfüllen. Die Aktie wird weiterhin unter dem Kürzel "RLYB" gehandelt. Fractional Shares werden in bar abgegolten.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rallybio Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260203651741) on February 03, 2026, and is solely responsible for the information contained therein.
Comments